By Connor Hart
IDEAYA Biosciences named Joshua Bleharski as its top finance chief, effective in early May.
Bleharski most recently served as managing director and global co-head of biopharma at J.P. Morgan, the South San Francisco, Calif., company said Monday. He held various roles of increasing responsibility over his nearly 17 years at the financial-services firm.
Prior, Bleharski worked as a senior staff scientist at a private biotechnology company in San Diego and was a post-doctoral fellow at the La Jolla Institute for Allergy and Immunology and the UCLA School of Medicine, the company said.
IDEAYA Biosciences said it expects to approve compensation terms of Bleharski, who is 50 years old, at a later date, according to a filing with the Securities and Exchange Commission.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
February 10, 2025 06:40 ET (11:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。